Medicis Declares Cash Dividend
December 15, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Dec. 15, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.06 per issued and outstanding share of...
Medicis to Present at Credit Suisse Health Care Conference
November 08, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 2010 Credit Suisse Health Care Conference in Phoenix, Arizona. A...
Medicis Reports Third Quarter 2010 Financial Results
November 04, 2010 16:05 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 4, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced revenues of approximately $177.3 million for the three months ended September 30, 2010, compared to revenues of...
Medicis Announces 2010 Third Quarter Conference Call and Webcast
November 02, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2010 third quarter financial results after the market closes on Thursday, November 4, 2010....
Medicis to Present at UBS Global Life Sciences Conference
September 20, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 20, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the UBS Global Life Sciences Conference in New York City. A live...
Medicis Declares Cash Dividend
September 15, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 15, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.06 per issued and outstanding share of...
Medicis to Present at Stifel Nicolaus Healthcare Conference
September 13, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Stifel Nicolaus 2010 Healthcare Conference in Boston,...
Medicis to Present at Morgan Stanley Healthcare Conference
September 10, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 10, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York City. A...
Medicis Announces New Patent for SOLODYN(R)
September 08, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,790,705 related to the...
Medicis Announces Approval of Additional Strengths of Solodyn(R)
August 30, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., Aug. 30, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN® (minocycline...